Glaukos Corporation (GKOS)
Makes tiny implants and drugs that lower eye pressure for glaucoma patients.
$148.68-0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+72.6%
The outlook
Glaukos is trading near the upper end of its 52-week range, with the price holding above both its 50- and 200-day moving averages. Analyst consensus leans strongly bullish, with an average price target sitting about 10% above the current level. The overall technical setup appears constructive relative to recent trading history.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range85% of the way from its 52-week low to high
Price targetAvg target +10% vs current price
Analyst price target
~12-month · 13 analysts$163.85average target+10.2% vs now
Now $148.68
Low $138.00High $190.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$8.73B
52-wk high
$161.53
52-wk low
$73.16
50-day avg
$136.59
200-day avg
$115.68
Trailing P/E
—